292 related articles for article (PubMed ID: 18512759)
21. Crosstalk between Cdk5/p35 and ERK1/2 signalling mediates spinal astrocyte activity via the PPARγ pathway in a rat model of chronic constriction injury.
Zhong Y; Chen J; Chen J; Chen Y; Li L; Xie Y
J Neurochem; 2019 Oct; 151(2):166-184. PubMed ID: 31314915
[TBL] [Abstract][Full Text] [Related]
22. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
Patrick GN; Zhou P; Kwon YT; Howley PM; Tsai LH
J Biol Chem; 1998 Sep; 273(37):24057-64. PubMed ID: 9727024
[TBL] [Abstract][Full Text] [Related]
23. Amelioration of social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit by N-acetylcysteine in a transgenic mouse model.
Hsiao YH; Kuo JR; Chen SH; Gean PW
Neurobiol Dis; 2012 Mar; 45(3):1111-20. PubMed ID: 22227002
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain.
Wang WY; Luo Y; Jia LJ; Hu SF; Lou XK; Shen SL; Lu H; Zhang HH; Yang R; Wang H; Ma ZW; Xue QS; Yu BW
Neuropharmacology; 2014 Feb; 77():90-9. PubMed ID: 24055498
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol inhibits Cdk5 activity through regulation of p35 expression.
Utreras E; Terse A; Keller J; Iadarola MJ; Kulkarni AB
Mol Pain; 2011 Jul; 7():49. PubMed ID: 21736731
[TBL] [Abstract][Full Text] [Related]
26. A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5).
Kaźmierczak A; Czapski GA; Adamczyk A; Gajkowska B; Strosznajder JB
Neurochem Int; 2011 Feb; 58(2):206-14. PubMed ID: 21130128
[TBL] [Abstract][Full Text] [Related]
27. Implication of cyclin-dependent kinase 5 in the neuroprotective properties of lithium.
Jordà EG; Verdaguer E; Canudas AM; Jiménez A; Garcia de Arriba S; Allgaier C; Pallàs M; Camins A
Neuroscience; 2005; 134(3):1001-11. PubMed ID: 15979805
[TBL] [Abstract][Full Text] [Related]
28. CDK5 activator protein p25 preferentially binds and activates GSK3β.
Chow HM; Guo D; Zhou JC; Zhang GY; Li HF; Herrup K; Zhang J
Proc Natl Acad Sci U S A; 2014 Nov; 111(45):E4887-95. PubMed ID: 25331900
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35.
Utreras E; Futatsugi A; Rudrabhatla P; Keller J; Iadarola MJ; Pant HC; Kulkarni AB
J Biol Chem; 2009 Jan; 284(4):2275-84. PubMed ID: 19049962
[TBL] [Abstract][Full Text] [Related]
30. A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons.
Alvarez A; Muñoz JP; Maccioni RB
Exp Cell Res; 2001 Apr; 264(2):266-74. PubMed ID: 11262183
[TBL] [Abstract][Full Text] [Related]
31. Extracellular alpha-synuclein induces calpain-dependent overactivation of cyclin-dependent kinase 5 in vitro.
Czapski GA; Gąssowska M; Wilkaniec A; Cieślik M; Adamczyk A
FEBS Lett; 2013 Sep; 587(18):3135-41. PubMed ID: 23954626
[TBL] [Abstract][Full Text] [Related]
32. Cyclin-dependent kinase 5 activator p35 over-expression and amyloid beta synergism increase apoptosis in cultured neuronal cells.
Utreras E; Maccioni R; González-Billault C
Neuroscience; 2009 Jul; 161(4):978-87. PubMed ID: 19362124
[TBL] [Abstract][Full Text] [Related]
33. Valproic acid downregulates Cdk5 activity via the transcription of the p35 mRNA.
Takahashi M; Ishida M; Saito T; Ohshima T; Hisanaga S
Biochem Biophys Res Commun; 2014 May; 447(4):678-82. PubMed ID: 24755075
[TBL] [Abstract][Full Text] [Related]
34. Involvement of calpain/p35-p25/Cdk5/NMDAR signaling pathway in glutamate-induced neurotoxicity in cultured rat retinal neurons.
Miao Y; Dong LD; Chen J; Hu XC; Yang XL; Wang Z
PLoS One; 2012; 7(8):e42318. PubMed ID: 22870316
[TBL] [Abstract][Full Text] [Related]
35. Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin-dependent kinase 5 activity in SH-SY5Y neuroblastoma cells and primary neurons.
Cho DH; Lee EJ; Kwon KJ; Shin CY; Song KH; Park JH; Jo I; Han SH
J Neurochem; 2013 Sep; 126(5):685-95. PubMed ID: 23581463
[TBL] [Abstract][Full Text] [Related]
36. Regulation and role of cyclin-dependent kinase activity in neuronal survival and death.
Hisanaga S; Endo R
J Neurochem; 2010 Dec; 115(6):1309-21. PubMed ID: 21044075
[TBL] [Abstract][Full Text] [Related]
37. Involvement of cAMP in nerve growth factor-triggered p35/Cdk5 activation and differentiation in PC12 cells.
Chen MC; Lin H; Hsu FN; Huang PH; Lee GS; Wang PS
Am J Physiol Cell Physiol; 2010 Aug; 299(2):C516-27. PubMed ID: 20463173
[TBL] [Abstract][Full Text] [Related]
38. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
[TBL] [Abstract][Full Text] [Related]
39. The presence of active Cdk5 associated with p35 in astrocytes and its important role in process elongation of scratched astrocyte.
He Y; Li HL; Xie WY; Yang CZ; Yu AC; Wang Y
Glia; 2007 Apr; 55(6):573-83. PubMed ID: 17295212
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective effects of emodin in rat cortical neurons against beta-amyloid-induced neurotoxicity.
Liu T; Jin H; Sun QR; Xu JH; Hu HT
Brain Res; 2010 Aug; 1347():149-60. PubMed ID: 20573598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]